Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa (SASS)

Laval University

Status and phase: Active, not recruiting; Early Phase 1

Conditions: Epidermolysis Bullosa Dystrophica

Treatments: Biological: SASS

Study type: Interventional

Funder types: Other

Identifiers

NCT04171661

LOEX 019

Details and patient eligibility

About

Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.

Enrollment: 1 patient

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

This clinical trial was custom designed for one patient

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1 participants in 1 patient group

SASS

Experimental group

Description:

SASS applied on chronic skin wounds as skin graft

Treatment:

Biological: SASS